{
    "Trade/Device Name(s)": [
        "Alinity m SARS-CoV-2"
    ],
    "Submitter Information": "Abbott Molecular Inc.",
    "510(k) Number": "K241580",
    "Predicate Device Reference 510(k) Number(s)": [
        "K213804"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QQX"
    ],
    "Summary Letter Date": "May 31, 2024",
    "Summary Letter Received Date": "June 3, 2024",
    "Submission Date": "December 4, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Anterior nasal swab"
    ],
    "Specimen Container(s)": [
        "Viral transport medium",
        "Universal transport medium",
        "Abbott Universal Collection Kit",
        "Abbott Universal Collection Kit II"
    ],
    "Instrument(s)/Platform(s)": [
        "Alinity m System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Magnetic microparticle-based nucleic acid extraction",
        "Automated sample preparation"
    ],
    "Methodologies": [
        "RT-PCR",
        "Qualitative nucleic acid detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control",
        "Software",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Alinity m SARS-CoV-2 real-time RT-PCR assay for qualitative detection of SARS-CoV-2 RNA on the automated Alinity m System.",
    "Indications for Use Summary": "Qualitative detection of SARS-CoV-2 RNA in nasopharyngeal and anterior nasal swab specimens from symptomatic patients as an aid in the diagnosis of COVID-19, used with the automated Alinity m System in conjunction with other clinical findings.",
    "fda_folder": "Microbiology"
}